NCT04240119View on ClinicalTrials.gov

Angiogenic Markers in Cerebrovascular Disease (ANFIS)

Enrolling by invitationOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2030

Study Completion Date

December 31, 2030

Conditions
StrokeTransient Ischemic AttackAtherosclerosisIntracranial Arterial StenosisMoyamoya
Interventions
OTHER

According to current clinical care standards

Enrolled subjects may be treated with medical management or surgically using indirect revascularization surgery.

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER